HomeDIXON › Filing

Announcement under Regulation 30 of SEBI LODR- Transcript of the Q4 FY 26 Earnings Conference Call held on 12th May, 2026

Filed: 15 May 2026, 17:37 IST Exchange: BSE Category: Financial Results — Earnings Call Transcript
AI summary - Q4FY26 revenue INR10,520 Cr; FY26 revenue INR48,893 Cr +26% y-y; EBITDA INR1,887 Cr +23% y-y; PAT INR845 Cr +20% y-y - Mobile volumes flat FY27 without Vivo; 12-15% price growth expected; Vivo volumes pending govt approval - Camera module capacity to expand from 70m to ~190m units in 15-18 months - Display JV trials start Q3FY27; mass production Q4FY27; target revenue INR5,500-6,000 Cr at double-digit margin - Telecom segment targeting INR7,500-8,000 Cr revenue in FY27; IT hardware revenue expected >INR4,000 Cr - Lighting revenues expected to double to ~INR1,700 Cr in FY27 - Industrial EMS business being developed with M&A focus; potential INR3,000-4,000 Cr size with higher margins - Working capital cycle negative 8 days; ROCE 44.8%, ROE 28.1%; capex ~INR1,000 Cr in FY27 - PLI income INR360 Cr booked FY26; receivables INR1,380 Cr; margin pressure from PLI phase-out partly offset by backward integration - Export growth planned in mobiles and lighting; server manufacturing discussions ongoing - Margin profile expected slightly under pressure in FY27, with margin expansion in FY28-29 from component integration
Source: Original filing PDF — view on exchange portal
Get filings like this on Telegram — in real time
Track Dixon Technologies (India) Limited and any other listed company. AI summaries, financial deltas, concall transcripts, insider trades — all delivered the moment they're filed.
Sign up free

More on Dixon Technologies (India) Limited

Important. The summary above is generated automatically from Dixon Technologies (India) Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.